Goldline acetaminophen lots recalled
IVAX Pharmaceuticals is recalling affected lots of Goldlineacetaminophen tablets and caplets due to a labeling error statingthat usage should not exceed 12 pills per 24 hours, instead of therecommended eight-pill maximum in a 24-hour period.
IVAX Pharmaceuticals is recalling affected lots of Goldline acetaminophen tablets and caplets due to a labeling error stating that usage should not exceed 12 pills per 24 hours, instead of the recommended eight-pill maximum in a 24-hour period. Specifically, the Extra Strength Genapap 500-mg and Extra Strength Genebs 500-mg tablets and caplets are affected. This inadvertent increase in the maximum daily dose of acetaminophen could put patients at risk for liver injury, although the company said it has received no reports of serious illness or injury related to the labeling mishap. For a list of affected lot numbers, pharmacists can visit
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
